Go Pro

Abivax (ABVX) News Today

Abivax logo
$114.79 +0.75 (+0.66%)
As of 09/4/2026 04:00 PM Eastern

Abivax Latest News

Abivax SA Sponsored ADR (ABVX) Gets a Hold from Wedbush
Abivax logo displayed in a laboratory setting with a microscope, vials, and lab equipment on a counter.
Abivax: Wall Street Catches Up to the Data
Abivax stock surged over 40% after positive Phase 3 data on ulcerative colitis drug Obefazimod and a $920 million share offering that underwriters fully exercised, signaling strong institutional demand.
Abivax launches $600M underwritten public offering
Abivax shares jump as updated trial data eases safety concerns

Abivax Media Mentions By Week

Abivax Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ABVX
News Sentiment

1.67

0.77

Average
Healthcare
News Sentiment

Abivax News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ABVX Articles
This Week

1

6

ABVX Articles
Average Week

Abivax Trends on MarketBeat

This week vs. last week
New Followers
1
-50%
Searches
1
Page Views
2,094
-12%
Get Abivax News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABVX and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Abivax dated 9/2/2026.
From Our Partners